世界の帯状疱疹感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Herpes Zoster Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2813
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、帯状疱疹感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、非経口）、用途別市場規模（クリニック、病院、診断センター、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・帯状疱疹感染症治療の市場動向
・企業の競争状況、市場シェア
・帯状疱疹感染症治療の種類別市場規模（経口、局所、非経口）
・帯状疱疹感染症治療の用途別市場規模（クリニック、病院、診断センター、在宅ケア）
・帯状疱疹感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・帯状疱疹感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・帯状疱疹感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・帯状疱疹感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・帯状疱疹感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bausch Health、Camber Pharmaceuticals、Novartis、Teva Pharmaceutical、Abbott、Merck）
・結論

Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.
Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.

Market Analysis and Insights: Global Herpes Zoster Infection Treatment Market
The global Herpes Zoster Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Zoster Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Zoster Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Zoster Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Zoster Infection Treatment market.

Global Herpes Zoster Infection Treatment Scope and Market Size
Herpes Zoster Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Zoster Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Topical
Parental

Segment by Application
Clinics
Hospitals
Diagnostic centers
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health
Camber Pharmaceuticals
Novartis
Teva Pharmaceutical
Abbott
Merck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Topical
1.2.4 Parental
1.3 Market by Application
1.3.1 Global Herpes Zoster Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic centers
1.3.5 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Herpes Zoster Infection Treatment Market Perspective (2016-2027)
2.2 Herpes Zoster Infection Treatment Growth Trends by Regions
2.2.1 Herpes Zoster Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Herpes Zoster Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Herpes Zoster Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Herpes Zoster Infection Treatment Industry Dynamic
2.3.1 Herpes Zoster Infection Treatment Market Trends
2.3.2 Herpes Zoster Infection Treatment Market Drivers
2.3.3 Herpes Zoster Infection Treatment Market Challenges
2.3.4 Herpes Zoster Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Herpes Zoster Infection Treatment Players by Revenue
3.1.1 Global Top Herpes Zoster Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Herpes Zoster Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Herpes Zoster Infection Treatment Revenue
3.4 Global Herpes Zoster Infection Treatment Market Concentration Ratio
3.4.1 Global Herpes Zoster Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Infection Treatment Revenue in 2020
3.5 Herpes Zoster Infection Treatment Key Players Head office and Area Served
3.6 Key Players Herpes Zoster Infection Treatment Product Solution and Service
3.7 Date of Enter into Herpes Zoster Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Zoster Infection Treatment Breakdown Data by Type
4.1 Global Herpes Zoster Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Herpes Zoster Infection Treatment Breakdown Data by Application
5.1 Global Herpes Zoster Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Herpes Zoster Infection Treatment Market Size (2016-2027)
6.2 North America Herpes Zoster Infection Treatment Market Size by Type
6.2.1 North America Herpes Zoster Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Herpes Zoster Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Herpes Zoster Infection Treatment Market Size by Type (2016-2027)
6.3 North America Herpes Zoster Infection Treatment Market Size by Application
6.3.1 North America Herpes Zoster Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Herpes Zoster Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Herpes Zoster Infection Treatment Market Size by Application (2016-2027)
6.4 North America Herpes Zoster Infection Treatment Market Size by Country
6.4.1 North America Herpes Zoster Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Herpes Zoster Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Herpes Zoster Infection Treatment Market Size (2016-2027)
7.2 Europe Herpes Zoster Infection Treatment Market Size by Type
7.2.1 Europe Herpes Zoster Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Herpes Zoster Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Herpes Zoster Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Herpes Zoster Infection Treatment Market Size by Application
7.3.1 Europe Herpes Zoster Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Herpes Zoster Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Herpes Zoster Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Herpes Zoster Infection Treatment Market Size by Country
7.4.1 Europe Herpes Zoster Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Herpes Zoster Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Herpes Zoster Infection Treatment Market Size (2016-2027)
9.2 Latin America Herpes Zoster Infection Treatment Market Size by Type
9.2.1 Latin America Herpes Zoster Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Herpes Zoster Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Herpes Zoster Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Herpes Zoster Infection Treatment Market Size by Application
9.3.1 Latin America Herpes Zoster Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Herpes Zoster Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Herpes Zoster Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Herpes Zoster Infection Treatment Market Size by Country
9.4.1 Latin America Herpes Zoster Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Herpes Zoster Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Herpes Zoster Infection Treatment Introduction
11.1.4 Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Camber Pharmaceuticals
11.2.1 Camber Pharmaceuticals Company Details
11.2.2 Camber Pharmaceuticals Business Overview
11.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Introduction
11.2.4 Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.2.5 Camber Pharmaceuticals Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Herpes Zoster Infection Treatment Introduction
11.3.4 Novartis Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Herpes Zoster Infection Treatment Introduction
11.5.4 Abbott Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Herpes Zoster Infection Treatment Introduction
11.6.4 Merck Revenue in Herpes Zoster Infection Treatment Business (2016-2021)
11.6.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Parental
Table 5. Global Herpes Zoster Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Herpes Zoster Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Herpes Zoster Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Herpes Zoster Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Herpes Zoster Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Herpes Zoster Infection Treatment Market Share by Regions (2022-2027)
Table 11. Herpes Zoster Infection Treatment Market Trends
Table 12. Herpes Zoster Infection Treatment Market Drivers
Table 13. Herpes Zoster Infection Treatment Market Challenges
Table 14. Herpes Zoster Infection Treatment Market Restraints
Table 15. Global Herpes Zoster Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Herpes Zoster Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Infection Treatment as of 2020)
Table 18. Ranking of Global Top Herpes Zoster Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Herpes Zoster Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Herpes Zoster Infection Treatment Product Solution and Service
Table 22. Date of Enter into Herpes Zoster Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Herpes Zoster Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Herpes Zoster Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Herpes Zoster Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Herpes Zoster Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Herpes Zoster Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Herpes Zoster Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Herpes Zoster Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Herpes Zoster Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Herpes Zoster Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Herpes Zoster Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Herpes Zoster Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Herpes Zoster Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Herpes Zoster Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Herpes Zoster Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Herpes Zoster Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Herpes Zoster Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bausch Health Company Details
Table 63. Bausch Health Business Overview
Table 64. Bausch Health Herpes Zoster Infection Treatment Product
Table 65. Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. Bausch Health Recent Development
Table 67. Camber Pharmaceuticals Company Details
Table 68. Camber Pharmaceuticals Business Overview
Table 69. Camber Pharmaceuticals Herpes Zoster Infection Treatment Product
Table 70. Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Camber Pharmaceuticals Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Herpes Zoster Infection Treatment Product
Table 75. Novartis Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Herpes Zoster Infection Treatment Product
Table 80. Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Herpes Zoster Infection Treatment Product
Table 85. Abbott Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Herpes Zoster Infection Treatment Product
Table 90. Merck Revenue in Herpes Zoster Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Zoster Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Topical Features
Figure 4. Parental Features
Figure 5. Global Herpes Zoster Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Clinics Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic centers Case Studies
Figure 9. Home Care Case Studies
Figure 10. Herpes Zoster Infection Treatment Report Years Considered
Figure 11. Global Herpes Zoster Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Herpes Zoster Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Herpes Zoster Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Herpes Zoster Infection Treatment Market Share by Regions (2022-2027)
Figure 15. Global Herpes Zoster Infection Treatment Market Share by Players in 2020
Figure 16. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Infection Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Herpes Zoster Infection Treatment Revenue in 2020
Figure 18. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Herpes Zoster Infection Treatment Market Share by Type (2016-2027)
Figure 22. North America Herpes Zoster Infection Treatment Market Share by Application (2016-2027)
Figure 23. North America Herpes Zoster Infection Treatment Market Share by Country (2016-2027)
Figure 24. United States Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Herpes Zoster Infection Treatment Market Share by Type (2016-2027)
Figure 28. Europe Herpes Zoster Infection Treatment Market Share by Application (2016-2027)
Figure 29. Europe Herpes Zoster Infection Treatment Market Share by Country (2016-2027)
Figure 30. Germany Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Herpes Zoster Infection Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Herpes Zoster Infection Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Herpes Zoster Infection Treatment Market Share by Region (2016-2027)
Figure 40. China Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Herpes Zoster Infection Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Herpes Zoster Infection Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Herpes Zoster Infection Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Herpes Zoster Infection Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Herpes Zoster Infection Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Herpes Zoster Infection Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Herpes Zoster Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bausch Health Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 60. Camber Pharmaceuticals Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の眼部帯状ヘルペス治療薬市場規模・現状・予測（2021年-2027年）

Global Herpes Zoster Ophthalmicus Drug Market Size, Status and Forecast 2021-2027
QYR2104Z2814 2021年4月 92Pages
QYResearch社発行の本調査資料では、眼部帯状ヘルペス治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年）

Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2811 2021年4月 130Pages
QYResearch社発行の本調査資料では、単純ヘルペスウイルス感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単純ヘルペスウイルス-1（HSV-1）感染、単純ヘルペスウイルス-2（HSV-2）感染、HSV1・HSV2同時感染）、用途...

世界の水痘帯状疱疹ウイルス（VZV）治療市場規模・現状・予測（2021年-2027年）

Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5863 2021年4月 93Pages
QYResearch社発行の本調査資料では、水痘帯状疱疹ウイルス（VZV）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、バラシクロビル、ファムシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地...

世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年）

Global Herpes Labialis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2808 2021年4月 96Pages
QYResearch社発行の本調査資料では、口唇ヘルペス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、バラシクロビル、ファムシクロビル、ペンシクロビル、ドコサノール）、用途別市場規模（局所、経口）、主要地域別市場規模（北米、...

世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年）

世界の尿路感染症治療市場規模・現状・予測（2021年-2027年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5835 2021年4月 98Pages
QYResearch社発行の本調査資料では、尿路感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（複雑UTI、再発性複雑UTI、単純UTI、神経因性膀胱感染症、その他）、用途別市場規模（病院薬局、婦人科及び泌尿器科クリニック、ドラッグス...

世界の耳感染症治療市場規模・現状・予測（2021年-2027年）

Global Ear Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2028 2021年4月 90Pages
QYResearch社発行の本調査資料では、耳感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、治療薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界の下気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3477 2021年4月 98Pages
QYResearch社発行の本調査資料では、下気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（支持療法、ホスピタルケア、医薬品、ワクチン）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、...

世界の全身感染症治療市場規模・現状・予測（2021年-2027年）

Global Systemic Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5539 2021年4月 99Pages
QYResearch社発行の本調査資料では、全身感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗ウイルス、防カビ）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5010 2021年4月 93Pages
QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、...

世界の眼部帯状ヘルペス治療薬市場規模・現状・予測（2021年-2027年） Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves. Market Analysis and Insights: Global Herpes Zoster Ophthalmicus Drug…
世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…
世界の水痘帯状疱疹ウイルス（VZV）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Varicella-Zoster Virus (VZV) Treatment Market The global Varicella-Zoster Virus (VZV) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の口唇ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…